mutations and complicated kar yotype. It follows a linear evolution in the CLL clone throughout the recurrent acquisition of CDKN2AGenetic susceptibility mechanisms. Most susceptibility loci map to non-coding areas with the genome, are generally situated in Energetic promoters or enhancers, and modify the binding web sites of quite a few transcript